Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

by lowes1 on September 23, 2013

Conditions:   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage III Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions:   Drug: nintedanib;   Other: laboratory biomarker analysis
Sponsors:   Roswell Park Cancer Institute;   Roswell Park Cancer Institute;   National Cancer Institute (NCI)
Not yet recruiting – verified September 2013

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

Leave a Comment

Previous post:

Next post: